Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Virtual reality (VR) is gaining traction as a legitimate tool in chronic pain management, moving well beyond novelty status. A meta-analysis of 122 randomized controlled trials found VR significantly reduced pain, and FDA-cleared programs like EaseVRx are now available for home use. Clinics across Germany are already integrating VR into multimodal pain programs, with promising results in both adults and children.
Virtual reality (VR) is stepping up as a meaningful complement to multimodal chronic pain therapy — and the evidence is starting to back it up. A meta-analysis of 122 randomized controlled trials (n = 9,138) found that VR produced a significant reduction in pain (SMD -0.65; P < .001), with stronger effects seen in patients with higher baseline pain. Unlike acute pain applications that focus purely on distraction, VR for chronic pain targets the cognitive and behavioral dimensions — think mobility, relaxation, motivation, and social functioning.
The technology has also become far more accessible. FDA-cleared programs like EaseVRx bring cognitive-behavioral therapy principles into immersive home-use formats, while lighter standalone headsets (like the Meta Quest 3) have removed the need for bulky, tethered equipment. Applications like ReliefVR use body illusions, gamified movement exercises, and distraction to help patients break avoidance cycles — with clinicians reporting patients spontaneously squatting, bending, and stretching mid-game when they'd avoided those movements for months.
Key Takeaways:
Why it matters: With millions of chronic pain sufferers facing therapist shortages, long wait times, and reimbursement gaps, scalable home-compatible VR tools could meaningfully expand access to evidence-based pain care.